## 

## 

|Trustees||Prof Dame<br>H J Stokes-Lampard|- Chair|
|---|---|---|---|
|||Mr C RTAskew||
|||MrJ Badyal||
|||Dr H0 Brunjes||
|||Ms P Dimond||
|||Mr BGudger||
|||Ms P R Hitchcox||
|||Ms SMetcalfe||
|||Ms G APalmer||
|Charity number||1191145||
|Company|number|12275770||
|Principal address||Southbank<br>Centre||
|||Belvedere Road||
|||London||
|||SE1 BXX||
|Registered|office|Southbank<br>Centre||
|||Belvedere Road||
|||London||
|||SE1SXX||
|Auditor||PKF Littlejohn<br>LLP||
|||15Westferry<br>Circus||
|||London||
|||E144HD||
|Solicitors||DAC Beachcroft LLP||
|||Portwall Place||
|||Portwall<br>Lane||
|||Bristol||
|||BS19HS||





## 




## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 



## 

## 

|||||Unrestricted|Restricted|Total|Restricted|
|---|---|---|---|---|---|---|---|
|||||funds|funds||funds|
|||||2023|2023|2023|2022|
||||Notes||6|6|6|
|Income and endowm||n||||||
|Grants|||3||3,471,951|3,471,951|2,909,180|
|Chaditable<br>activities|||4||117,008|117,008|250,284|
|Other income|||5|309,020||309,020||
|Total income||||309,020|3,588,959|3,897,979|3,159,464|
|~dd**<br>ddb|i|||||||
|Charitable<br>activities|||||3,372,410|3,372,410|3,014,057|
|Net income for the year/||||||||
|Net movement|in funds|||309,020|216,549|525,569|145,407|
|Fund balances at 1 April||2022|||233,307|233,307|87,900|
|Fund balances|at 31 March 2023|||309,020|449,856|758,876|233,307|





## 

## 

## 

|||Notes|2023<br>f||2022<br>f||
|---|---|---|---|---|---|---|
|Fixed assets|||||||
|Tangible assets||||31,273||41,272|
|Current assets|||||||
|Debtors||12|402,091||394,855||
|Cash at bank and in|hand||844,639||618,498||
||||1,246,730||1,013,353||
|Creditors: amounts|falling due within||||||
|one year||13|(519,127)||(821,318)||
|Net current assets||||727,603||192,035|
|Total assets less current liabilities||||758,876||233,307|
|Income funds|||||||
|Restricted funds||15||449,856||233,307|
|Unrestdicted<br>funds||||309,020|||
|||||758,876||233,307|





## 

## 

## 

|||||2023||2022|
|---|---|---|---|---|---|---|
||||Notes||||
|Cash flows from operating||activities|||||
|Cash generated|from/(absorbed<br>by)||18||||
|operations|||||235,101|(1,920,197)|
|Investing<br>activities|||||||
|Purchase oftangible<br>fixed assets||||(8,960)||(17,222)|
|Net cash used|in investing|activities|||(8,960)|(17,222)|
|Net cash used|in financing|activities|||||
|Net increase/(decrease)<br>in||cash and|cash||||
|equivalents|||||226,141|(1,937,419)|
|Cash and cash|equivalents|at beginning|ofyear||618,498|2,555,917|
|Cash and cash|equivalents|at end of|year||844,639|618,498|





## 

||Accounting<br>policies||||||||
|---|---|---|---|---|---|---|---|---|
||Charity information||||||||
||The National<br>Academy<br>for Social Prescribing<br>is|a private<br>company|limited<br>by guarantee||incorporated|||in|
||England<br>and Wales. The registered<br>office is Southbank<br>Centre, Belvedere Road, London, SE18XX.||||||||
||Accounting<br>convention||||||||
||The financial<br>statements<br>have<br>been<br>prepared<br>in|accordance<br>with<br>the charity's<br>governing|||document,|||the|
||Companies<br>Act 2006 and<br>"Accounting<br>and<br>Reporting<br>by Charities:<br>Statement<br>of Recommended||||||Practice||
||applicable<br>to charities<br>preparing<br>their<br>accounts<br>in accordance<br>with<br>the<br>Financial<br>Reporting<br>applicable<br>in the UK and Republic of Ireland (FRS 102) (elfective<br>1 January 2019)".The charity|||||Standard<br>is a Public|||
||Benefit Entity as defined<br>by FRS 102.||||||||
||The financial<br>statements<br>are prepared<br>in sterling,<br>amounts<br>in these financial statements<br>are rounded|which<br>is the functional<br>currency<br>to the nearest f1.||of the|charity.||Monetary||
||The financial<br>statements<br>have been prepared<br>under the histodical<br>cost||convention.|The principal||accounting|||
||policies adopted are set out below.||||||||
|1.2|Going concern||||||||
||The financial<br>statements<br>have been prepared<br>on|the going<br>concern|basis. The|trustees|have|considered|||
||relevant<br>information,<br>including<br>future cash flow forecasts and the impact||ofsubsequent<br>events<br>in making|||||their|
||assessment.||||||||
||Based on these assessments<br>and<br>having<br>regard|to the resources<br>available<br>to the entity,|||the trustees<br>have||||
||concluded<br>that there<br>is no material<br>uncertainty<br>in|relation<br>to the appropdiateness||of continuing<br>to|||adopt|the|
||going concern basis in preparing<br>the annual<br>report|and financial statements.|||||||
|1.3|Charitable<br>funds||||||||
||Restricted<br>funds are subject to specific conditions|by donors as to how|they may be used. The purposes|||||and|
||uses ofthe restricted<br>funds are set out in the notes|to the financial statements.|||||||
|1.4|Income||||||||
||Income from government<br>grants is recognised<br>when the charity has entitlement<br>to the funds,||||any performance||||
||conditions<br>attached<br>to the grants<br>have<br>been<br>met,<br>it is probable<br>that||the income|will be|received||and|the|
||amount can be measured<br>reliably.||||||||
|1.5|Expenditure||||||||
||Expenditure<br>relating to charitable<br>activities<br>is included<br>in the Statement||of Financial|Activities<br>on an|||accruals||
||basis.||||||||
||Support costs include<br>amounts<br>incurred<br>in respect|of the running<br>ofthe|charity as|an organisation,|||including||
||general<br>management,<br>administration<br>and the finance function. The bases on which|||support|costs|have been|||
||allocated are set out in note 8.||||||||
||Governance<br>costs include<br>staff costs incurred<br>to <br>bases on which support costs have been allocated|support<br>governance<br> are set out in note 8.|and<br>legal and professional||||fees.|The|





## 

## 

## 



## 

## 

## 

|||2023|2022|
|---|---|---|---|
|||6|6|
|Grants receivable||3,471,951|2,909,180|
|Grants receivable for core activities||||
|Department<br>of|Health and Social Care|3,077,789|2,854,706|
|Sport England||85,350|42,675|
|Lego Company|Ltd|183,500||
|IndependentAge||109,560||
|Other||15,752|11,799|
|||3,471,951|2,909,180|





## 

## 

|||Unrestricted|Total|
|---|---|---|---|
|||funds||
|||2023f|2022f|
|Other|income|309,020||





|||||ID<br>I-|||DI <br>NON|W|||Ol<br>CO<br>N|O<br>OO<br>O<br>CA|Ol<br>CD<br>CO <br>CO|Ol<br>CD<br>CO <br>CO|CA<br>IA<br>f<br>CD<br> co|ItoO<br>O|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||||||||CO|
|||||0|ID||N <br>NO|W|||||O<br>Cl<br>Cl||||
|||||g|Ol<br>IU||||||||to||||
|||||Ol<br>fll<br>.C.N||Cl<br> E|N<br>N<br>CI|W|||N||||||
||||||||N||||||||||
|||||I|E|h|||||to<br>CO|||||CO<br>CO|
|||||0<br>E<br>0|E0<br>CL<br>0<br>ol<br>CD<br>0,<br>0 NE<br>fD 0<br>M<br>e||OI <br>N<br>Cl|W|CA<br>CO<br>to|IA<br>CD<br>Ol|0<br>I<br>DI<br>O|O<br>O<br>O<br>O<br>CA<br>N|N<br>CO <br>CO||CA<br>IA<br>I<br>Ol<br> co|IA<br>O<br>N|
|||||IM|||||||||||||
|||||ttl<br>Io|||CO <br>N|W|||DI<br>O<br>CD|OO<br>O<br>O|CO<br>CD<br>OI <br>O<br>N|<br>|CO<br> O<br> N|CI<br>N<br>I|
||||||||||||Ol||CA||||
|||||||||||||||||CD|
|||||0<br>O.|ID<br>Ol||N<br>N|W|||||||||
||||||UI||||||||||||
|0Z<br>IXI<br>ILU<br>V)<br>UJ<br>LL0.<br>c(<br>U0<br>V)<br>0|CI<br>IU<br>zI-z0<br>U<br>IIII-z<br>IUZ<br>IUI-|CD<br>CCI<br>V||CD<br>0 <br>I- <br>0 <br>E<br>O<br>0.|ID<br>ID<br> 0<br>al<br> E<br>OI<br>E00<br>0<br>Ol<br> N<br>0,<br>N<br>ID<br>e<br>CD||CO<br>N<br>N<br>CD <br>N<br>Cf<br>N|Cfl<br> tll|CD<br>O<br>IOO <br>CO <br>IO<br>Ol <br>IO|IA<br>CO<br>IO<br> toto<br>CD<br> O<br>Ol<br> O<br>IA|CO<br>CO<br>CD<br>Ct|OOO<br>O|~D <br>IA <br>CD <br>I<br>N|<br> <br>|to<br> O<br> C9<br>Al<br>CO|Ct<br>C<br>CD<br>to<br>N|
|Z<br>Cic(<br>U<br>Z<br>I2<br>Z<br>ZI-|III<br>cE<br>Uz<br>MEz<br>IUXI-0I-<br>III<br>IUI-0z|O<br>CI<br>UI<br>UI<br>4.0|ffl<br>Dl<br>V<br>ID<br>Dl<br>Zl<br>ttl<br>Dl<br>O||||||M<br>Cl <br>0 <br>0<br>CO|M<br>M<br> 0<br> 0<br> 0||000<br>ID<br>Dltc<br>N<br>CD<br>0cl<br>0<br>0'0<br>0tc0|00 <br>C<br>M<br>N <br>N<br>0 <br>0<br>0<br>CL <br>O. <br>N<br>0 <br>Cl <br>DI<br>CO|Cl0<br>0<br> 0<br>N<br>+M0<br> 0<br>Dl<br> 0<br>C<br>tD<br> 0<br> 0<br>Ol<br> 0<br> 0<br>CD<br>CO|||





## 

## 

||||Promotion|Promotion<br>of|
|---|---|---|---|---|
||||ofsocial|social|
||||prescribing|prescribing|
||||2023|2022f|
|Grants to institutions:|||||
|World Health<br>Innovation||Summit CIC||90,000|
|Royal Voluntary|Service|||100,000|
|English<br>National|Opera|||40,000|
|College of Medicine|||10,000||
||||10,000|230,000|



|Support|co|sts||||||
|---|---|---|---|---|---|---|---|
||||Support|Governance|2023|2022|Basis ofallocation|
||||costs|costs||||
||||f.|f||||
|Staff costs|||578,579|38,793|617,372|528,621|Time spent|
|Other costs|||722,759|84,288|807,047|514,964|Direct|
|Depreciation||and|18,958||18,958|14,280|Direct|
|impairment||||||||
||||1,320,296|123,081|1,443,377|1,057,865||
|Analysed|between|||||||
|Charitable|activities||1,320,296|123,081|1,443,377|1,057,865||



## 



## 

## 

## 

|Employment<br>costs|2023|2022|
|---|---|---|
||6|6|
|Wages and salaries|1,212,247|1,160,087|
|Social security costs|131,339|37,840|
|Other pension costs|32,325|10,521|
||1,375,911|1,208,448|



||The num<br>were:|ber|of emplo|yees<br>whose annual<br>remunera|tion<br>was f60,000 or more|||
|---|---|---|---|---|---|---|---|
|||||||2023|2022|
|||||||Number|Number|
||660,000|—670,000||||1||
||670,000|- F80,000||||1||
|11|Tangible|fixed assets||||||
||||||Fixtures and|Computer|Total|
||||||fittings|equipment||
||||||6|||
||Cost|||||||
||At 1 April|2022|||6,215|51,354|57,569|
||Additions||||137|8,823|8,960|
||At 31 March||2023||6,352|60,177|66,529|
||Depreciation||and impairment|||||
||At 1 April|2022|||532|15,765|16,297|
||Depreciation||charged|in the year|1,447|17,512|18,959|
||At 31 March||2023||1,979|33,277|35,256|
||Carrying|amount||||||
||At 31 March||2023||4,373|26,900|31,273|
||At 31 March||2022||5,683|35,589|41,272|





## 

## 

|12|Debtors||||||
|---|---|---|---|---|---|---|
||Amounts<br>falling due|within one year:|||2023f|2022f|
||Trade debtors||||357,411|288,424|
||Other debtors|||||3,190|
||Prepayments<br>and accrued income||||44,680|103,241|
||||||402,091|394,855|
|13|Creditors: amounts|falling due within one year|||||
|||||Notes|2023f|2022<br>f|
||Other taxation and social||security||15,604||
||Deferred income|||14|266|198,694|
||Trade creditors||||390,212|508,404|
||Other creditors||||4,754|3,953|
||Accruals||||108,291|110,267|
||||||519,127|821,318|
|14|Deferred income||||||
||||||2023f|2022f|
||Arising from Department||of Health and Social||||
||Care grant|||||198,694|
||Arising from other grants||||266||
||||||266|198,694|





|||||th<br>dl<br>M0<br>CL<br>CL0<br>I<br>U<br>Cl<br>CL<br>N<br>0<br>N<br>C0<br>'Oe|4-<br>C<br>c<br>(0<br>E<br>e <br>X|N N<br>alo<br>u N<br>Cc<br>al<br>al<br>IQg<br>ta<br>al 'o<br>4I 4(<br>U O<br>0 (L<br>"x<br>O. o<br>otal<br>Cd(<br>'<br>U<br> oo<br>u<br>oN|(Q(0<br>Ol<br>Cl<br>(Q|(DO'O<br>O Q<br>Ol<br>(O O<br>(S<br>O<br>(O<br>IA<br>(Q <br>IO <br>Gl<br>N<br>' O<br>(D<br>O<br>(0 Ol<br>(A<br>IO (D<br>O<br>Ol O<br>O<br>O<br>OO<br>(0<br>O<br>' O<br>IA<br>(O I<br>tp O<br>IA<br>(0<br>(0<br>O<br>(Q<br>O <br>O <br>O <br>(o <br>(«I|(0<br> (4<br>(Q<br> N<br>Ol<br>t<br>(D<br> O<br> O<br> tp<br> al<br>«Q|(0<br> (4<br>(Q<br> N<br>Ol<br>t<br>(D<br> O<br> O<br> tp<br> al<br>«Q|O<br>OO<br>O<br>(«I<br>0<br>0 <br>O<br>O <br>44|'<br>IA<br>CO<br>O(0<br>Dl<br>(Q<br>aj IA<br>Dl<br>0 (0<br> (0 (Q<br>Ol<br>Dl<br> (0<br>(«I<br>IA|'<br>IA<br>CO<br>O(0<br>Dl<br>(Q<br>aj IA<br>Dl<br>0 (0<br> (0 (Q<br>Ol<br>Dl<br> (0<br>(«I<br>IA|(S<br>CI(<br>(Q|O<br>(0<br>(0<br>al<br>M<br>dl<br>0<br>Cl<br>CL<br>Cl<br>0<br>h.E<br>0<br>Ctp0<br>6:<br>Gl00<br>N<br>NN<br>IDUO(0<br>0<br>er<br>ta<br>ID<br>O.0<br>Cl<br>CL<br>0<br>NerE||(0<br>CZ<br>5e0<br>taO<br>M<br>Q.<br>'O<br>tae|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||al<br>(0h0<br>Gl||N<br>O hl<br>al O<br>U I«<br>C—<br>la 'C<br>N h<br>((I &||CI O<br>'<br>IA<br>IA OO<br>Ol<br>Dl O<br>DlN|||||CI<br>CI|Q(o<br>Pl|M<br>Cl<br>0<br>Gl<br>(D<br>M<br>C<br>4l<br>e<br>N(0<br>ID||m Z<br>N<br>0<br>C<br>Z<br>m<br>m (L|
|QZ<br>IQ<br>RU<br>tO<br>IJJ<br>IL<br>U0<br>tO<br>L0<br>UJO<br>U<br>Z0<br>Z<br>ZI-|Ci<br>UJDZI-Z0<br>U<br>iflI-Z<br>UJX<br>IJJ<br>Vl<br>UX<br>ax<br>UJzI-0I-<br>VJ<br>IIJI-0X|Pl<br>CD<br>U<br>CI<br>CI<br>IIJ<br>Ii.0|dl<br>'O<br>C<br>'O<br>Cl0<br>N<br>4I<br>JK|N<br>0<br>GlC0O<br>0<br>Ih<br>dlU<br>Gl<br>Gl<br>10e<br>4lO.x<br>dlC<br>Ol<br>00<br>(D<br>0(<br>Ih<br>CL<br>E00<br>N<br>'O<br>0<br>Cl<br>p<br>Ne<br>e<br>pC<br>ta<br>0<br>Cl<br>0<br>N<br>tdC<br>IDE00<br>e|N<br>'O<br>e <br>e <br>0|N '0<br>al<br>CI<br>U 10<br>O C<br>o~~<br>4I"x<br>(0<br>Ol U<br> c al<br> OE**.**<br>uCIh<br> —4I<br>Cl O<br>U aa<br>C-<br>Ill C<br>NO<br>m&|Q<br>(Q<br>IO<br>ao<br>Ol<br>CI<br>(Q<br>IO<br>(Q<br>(«I<br>e<br>hO<br>4!00<br>DJ<br>'tl<br>m<br>(D<br>IDZ<br>0<br>C<br>0l<br>Y <br>al <br>e<br>QJ|CIO<br>to<br>10<br>Gl<br>Ol<br> lU<br>«C<br>c<br> Yp<br>LL<br>D. lU<br>(Q<br>Qt<br>040<br>e<br>C<br>Gl<br>C<br>Ol<br>4I c<br>'0<br>UJ<br>C<br>Cl<br>m<br>lU<br>al 0 (A<br>CZZ<br>IA Q '(t O<br>'«t<br>O<br>I<br>O<br>(D<br>(OOOO<br>(«I Q<br>IA O<br>IA|D <br>c<br>O. <br>0 <br>O<br>0<br>ch <br>Cl<br>dl|c<br> .0<br>(0<br> PC<br> 0<br>LL<br> e<br>m||UJO<br>6!<br>Ol<br>UJ<br>0<br>0O<br>&|Q<br>CI<br>.c<br> 0|(D<br>tp<br>CI<br>Q<br>(Q<br>CIO|Cl<br>0<br>0<br>dl<br>000<br>ID<br>CL0<br>4lO.<br>0<br>CL<br>N0<br>O<br>Gl<br>O<br>0<br>Ol<br>O<br>th<br>paf0<br>(S<br>(0<br>(4<br>h<br>0<br>(D<br>0<br>03e0<br>U<br>O e<br>Vic<br>X<br>O 0<br>C0<br>Id<br>(0<br>Cl0 0<br>to "<br>'0ce<br>td Y<br>r 0<br>CL<br>e<br>QL<br>ID<br>(0<br>0<br>0<br>thdl<br>0<br>(0'0<br>to<br>th<br>Gl<br>C<br>EE<br>8<br>C<br>Dm<br>CL<br>m .0<br>60<br>CT dl<br>'t3<br>Gl<br>(0<br>th<br>fh<br>m h<br>6! p<br>m<br>dlOlr<br>4I<br>e c<br>C<br>(D<br>JD<br>Ol<br>c '<br>E c c<br>e Oo<br>al<br>0(<br>eah<br>4I<br>QJ t- h.|C<br>Gl<br>Ol<br>C<br>(U<br>OlY<br>.E 0<br>6 O.<br>0 (A<br>**O** 0<br>—(0<br>E Z<br>E<br>ID<br>m0<br>h3<br>O<br>al<br>D p<br>?c<br>0 0<br>mo<br>o<br>m<br>(4 C<br>co<br>Q. E<br>3, E<br>m ol<br>c 0<br>Oc N<br>ID e<br>O C<br>O. P<br>o.E<br>o E<br>N<br>OO<br>Ol<br>c c<br>Cl 'E.c<br>ec<br>e I—<br>bl<br>ID<br>td C<br>OlY<br>C p<br>8 a<br>C 0<br>M<br>h o<br>U, al<br>e<br>Ol<br>Eo<br>Cl<br>td<br>N<br>th<br>00<br>dh<br>Y hth'<br>0<br>th<br>(0<br>Gl<br>(DI- 0||



## 



## 

## 

|Analysis ofnet assets between funds|||||
|---|---|---|---|---|
||Unrestricted|Restricted|Total|Restricted|
||funds|funds||funds|
||2023|2023|2023|2022|
||||6|f|
|Fund balances at 31 March 2023 are represented|||||
|by:|||||
|Tangible assets||31,273|31,273|41,272|
|Current assets/(liabilities)|(53836)|781439|727,603|192,035|
||(53,836)|812,712|758,876|233,307|



## 

|18|Cash generated<br>from|operations|||2023|2022f|
|---|---|---|---|---|---|---|
||Surplus<br>for the year||||525,569|145,407|
||Adjustments<br>for:||||||
||Depreciation<br>and impairment<br>oftangible|||fixed assets|18,959|14,280|
||Movements<br>in working|capital:|||||
||(Increase)<br>in debtors<br>(Decrease) in creditors||||(7,236)<br>(103,763)|(314,794)<br>(286,541)|
||(Decrease) in deferred|income|||(198,428)|(1,478,549)|
||Cash generated<br>from/(absorbed||by) operations||235,101|(1,920,197)|



